CGON
Income statement / Annual
Last year (2025), Cg Oncology Inc.'s total revenue was $4.04 M,
an increase of 254.70% from the previous year.
In 2025, Cg Oncology Inc.'s net income was -$161.00 M.
See Cg Oncology Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$4.04 M |
$1.14 M |
$204.00 K |
$191.00 K |
$10.36 M |
| Cost of Revenue |
$4.65 M
|
$0.00
|
$0.00
|
$15.00 K
|
$10.00 K
|
| Gross Profit |
-$607.00 K
|
$1.14 M
|
$204.00 K
|
$176.00 K
|
$10.35 M
|
| Gross Profit Ratio |
-0.15
|
1
|
1
|
0.92
|
1
|
| Research and Development Expenses |
$116.64 M
|
$82.10 M
|
$45.75 M
|
$29.03 M
|
$18.32 M
|
| General & Administrative Expenses |
$73.53 M
|
$33.70 M
|
$9.90 M
|
$6.41 M
|
$4.65 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
-$15.00 K
|
-$10.00 K
|
| Selling, General & Administrative Expenses |
$73.53 M
|
$33.70 M
|
$9.90 M
|
$6.39 M
|
$4.64 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$190.17 M
|
$115.81 M
|
$55.65 M
|
$35.42 M
|
$22.95 M
|
| Cost And Expenses |
$194.81 M
|
$115.81 M
|
$55.65 M
|
$35.44 M
|
$22.96 M
|
| Interest Income |
$0.00
|
$26.62 M
|
$6.90 M
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$1.00 K
|
$451.00 K
|
| Depreciation & Amortization |
$1.45 M
|
$32.00 K
|
$17.00 K
|
$15.00 K
|
$10.00 K
|
| EBITDA |
-$159.55 M |
-$114.63 M |
-$55.43 M |
-$35.23 M |
-$12.38 M |
| EBITDA Ratio |
-39.49
|
-100.64
|
-271.73
|
-184.46
|
-1.2
|
| Operating Income Ratio |
-47.22
|
-100.67
|
-271.81
|
-184.53
|
-1.22
|
| Total Other Income/Expenses Net |
$29.78 M
|
$26.63 M
|
$6.84 M
|
-$197.00 K
|
-$233.00 K
|
| Income Before Tax |
-$161.00 M
|
-$88.04 M
|
-$48.61 M
|
-$35.44 M
|
-$12.84 M
|
| Income Before Tax Ratio |
-39.85
|
-77.29
|
-238.27
|
-185.57
|
-1.24
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$161.00 M
|
-$88.04 M
|
-$48.61 M
|
-$35.44 M
|
-$12.84 M
|
| Net Income Ratio |
-39.85
|
-77.29
|
-238.27
|
-185.57
|
-1.24
|
| EPS |
-2.08 |
-1.41 |
-1.02 |
-0.66 |
-0.28 |
| EPS Diluted |
-2.08 |
-1.41 |
-1.02 |
-0.66 |
-0.28 |
| Weighted Average Shares Out |
$77.30 M
|
$62.50 M
|
$66.64 M
|
$66.64 M
|
$66.64 M
|
| Weighted Average Shares Out Diluted |
$77.30 M
|
$62.50 M
|
$66.64 M
|
$66.64 M
|
$66.64 M
|
| Link |
|
|
|
|
|
